New York City, NY., July 29th, 2021 – The National Kidney Foundation (NKF) is pleased to announce that Susan Thrope and Dr. Vesh Srivatana have joined NKF Serving Greater New York & Connecticut Board to help support NKF’s effort to increase awareness and advance the prevention and treatment of kidney disease. This year, more than ever before, we must emphasize the importance of good kidney health and the unique risk and burden kidney patients face with COVID-19.
“We’re excited to expand our board with members who will bring diverse experiences and insight to our work,” said William G. Dessoffy, Board Chair. “We have worked diligently to ensure that our Board leadership represents a variety of experts from numerous fields. The kidney community needs our help now more than ever, so we’re thrilled to bring these new members on board to support the critical work we do,” he added.
Ms. Thrope retired as the Senior Vice President, Deputy General Counsel and Corporate Secretary of New York Life Insurance Company where she was employed for almost 35 years. During her tenure at New York Life, Susan held myriad managerial and leadership positions both within the legal and business areas of the Company and was a member of New York Life's Executive Management. “I’m so honored to join the NKF Serving the Greater New York & Connecticut Board and to lend my support to promote awareness and early detection of kidney disease,” said Susan Thrope, Board Member. Caring for family members who live with renal disease, Susan has an understanding and appreciation for the mission and purpose of the NKF. She is eager to take an active role in helping to advance NKF's efforts in scientific research, advocacy, and education by joining the board of the National Kidney Foundation of Greater New York.
Dr. Vesh Srivatana is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and Assistant Attending Physician at New York-Presbyterian Hospital. He serves as the Director of Peritoneal Dialysis at The Rogosin Institute. He studied medicine at SUNY Upstate Medical University and completed Internal Medicine Residency at Stony Brook University Hospital where he also served as Chief Resident. Dr. Srivatana went on to complete nephrology fellowship at Weill Cornell Medicine. He specializes in the care of peritoneal dialysis patients and strives to develop an individualized treatment plan and relationship with each patient and family. Srivatana was active in the care of nephrology and peritoneal dialysis patients during the peak of the COVID-19 pandemic. He and his team were recipients of the KidneyX COVID-19 Kidney Care Challenge award for the development of novel peritoneal dialysis training protocols during COVID-19. Dr. Srivatana recently joined the NKF Kidney Outreach Team serving as a voice by increasing awareness of chronic kidney disease (CKD), dialysis, transplantation, and organ donation with elected officials through legislative advocacy activities. “I plan to do all that I can to support NKF and advance their critical mission to help the 37 million adults in the U.S. affected by kidney disease.” said Srivatana.
In addition to Board appointments, NKF Serving Greater New York and Connecticut hosts Medical Symposiums and Kidney Walks each year to increase awareness about kidney health and the prevention and treatment of kidney disease. Organizers urge event supporters and the public to make an explicit commitment to find out if they are at risk for kidney disease, like the 1 in 3 adults in the U.S. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history. Since kidney disease often has no symptoms, it’s important for everyone to get their kidneys checked regularly. Finding out if you’re at risk is easy with a one-minute quiz at www.MinuteForYourKidneys.org.
The NKF Board of Directors consist of leaders in their communities who have been affected by kidney disease. They are nephrologists, kidney healthcare professionals, living donors, transplant recipients, care partners, top executives with diverse business experiences, and civic leaders.
About Kidney Disease
In the United States, 37 million adults are estimated to have chronic kidney disease—and approximately 90 percent don’t know they have it. 1 in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history. People of African American, Hispanic, American Indian, Asian, or Pacific Islander descent are at increased risk for developing the disease. African Americans are almost 4 times more likely than White Americans to have kidney failure. Hispanics are 1.3 times more likely than non-Hispanics to have kidney failure.
The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org.